TYPE-2 AND TYPE-3 GAUCHER DISEASE - A MORPHOLOGICAL AND BIOCHEMICAL-STUDY

[21] OBERLING CH., 1927, REV FRANC PEDIATRIE, V3, P475

[22] PHILIPPART M, 1967, INBORN DISORDERS SPH, P389

[23] ROUSER G, 1970, J AM OIL CHEM SOC, V42, P404

[24] SCHAIRER E, 1942, ARCH PATH ANAT, V309, P726

[25] SCHAIRER E, 1948, ARCH PATH ANAT, V315, P395

[26] SUDO M, 1977, J NEUROCHEM, V29, P379

[27] ULLMAN MD, 1978, J LIPID RES, V19, P910

[28] ULLMAN MD, 1977, J LIPID RES, V18, P371

[29] VANIER MT, 1976, CURRENT TRENDS SPHIN, P115

[30] WILSON ER, 1985, ARCH PATHOL LAB MED, V109, P82

[21] OBERLING CH., 1927, REV FRANC PEDIATRIE, V3, P475

[22] PHILIPPART M, 1967, INBORN DISORDERS SPH, P389

[23] ROUSER G, 1970, J AM OIL CHEM SOC, V42, P404

[24] SCHAIRER E, 1942, ARCH PATH ANAT, V309, P726

[25] SCHAIRER E, 1948, ARCH PATH ANAT, V315, P395

[26] SUDO M, 1977, J NEUROCHEM, V29, P379

[27] ULLMAN MD, 1978, J LIPID RES, V19, P910

[28] ULLMAN MD, 1977, J LIPID RES, V18, P371

[29] VANIER MT, 1976, CURRENT TRENDS SPHIN, P115

[30] WILSON ER, 1985, ARCH PATHOL LAB MED, V109, P82